Shopping Cart
Remove All
Your shopping cart is currently empty
Taplitumomab
🥰Excellent
Catalog No. T9901A-2013
Taplitumomab is a monoclonal antibody targeting CD19 on B lymphocytes. Taplitumomab can be used for B-cell biology and immuno-oncology research.
Taplitumomab
Taplitumomab
🥰Excellent
Catalog No. T9901A-2013
Taplitumomab is a monoclonal antibody targeting CD19 on B lymphocytes. Taplitumomab can be used for B-cell biology and immuno-oncology research.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Taplitumomab is a monoclonal antibody targeting CD19 on B lymphocytes. Taplitumomab can be used for B-cell biology and immuno-oncology research. |
| Reactivity | Human |
| Application | Functional assay |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD19, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, Differentiation antigen CD19, T-cell surface antigen Leu-12 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | Lyophilized powder: -20~-80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Taplitumomab | purchase Taplitumomab | Taplitumomab cost | order Taplitumomab
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.